These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27317516)
21. Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias. Zagouri F; Roussou M; Kastritis E; Koureas A; Tsokou E; Migkou M; Gavriatopoulou M; Nikitas N; Gkotzamanidou M; Terpos E; Dimopoulos MA Am J Hematol; 2011 Oct; 86(10):882-4. PubMed ID: 21818766 [No Abstract] [Full Text] [Related]
22. Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era. Zago M; Adam P; Goldschmidt H; Fend F; Kanz L; Weisel K Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):e7-e11. PubMed ID: 24169269 [No Abstract] [Full Text] [Related]
23. Role of lenalidomide in the treatment of multiple myeloma and myelodysplastic syndrome. Maier SK; Hammond JM Ann Pharmacother; 2006 Feb; 40(2):286-9. PubMed ID: 16403850 [TBL] [Abstract][Full Text] [Related]
24. Lenalidomide in myelodysplastic syndromes. List AF Clin Adv Hematol Oncol; 2008 Apr; 6(4):271-2, 311. PubMed ID: 18496493 [No Abstract] [Full Text] [Related]
25. Lenalidomide in the treatment of multiple myeloma: a review. Armoiry X; Aulagner G; Facon T J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408 [TBL] [Abstract][Full Text] [Related]
26. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. Weber DM; Chen C; Niesvizky R; Wang M; Belch A; Stadtmauer EA; Siegel D; Borrello I; Rajkumar SV; Chanan-Khan AA; Lonial S; Yu Z; Patin J; Olesnyckyj M; Zeldis JB; Knight RD; N Engl J Med; 2007 Nov; 357(21):2133-42. PubMed ID: 18032763 [TBL] [Abstract][Full Text] [Related]
27. Pomalidomide: when expectations are understated. Di Raimondo F; Conticello C Future Oncol; 2017 Feb; 13(5s):1-2. PubMed ID: 28116940 [No Abstract] [Full Text] [Related]
29. Use of Lenalidomide in 5q-Myelodysplastic Syndrome Provides Novel Treatment Prospects in Management of Pulmonary Sarcoidosis. Giv MJ; Yoosuff A; Bazargan A Chest; 2015 Aug; 148(2):e35-e37. PubMed ID: 26238834 [TBL] [Abstract][Full Text] [Related]
30. Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug. Ramsay AG; Gribben JG Haematologica; 2009 Sep; 94(9):1198-202. PubMed ID: 19734414 [TBL] [Abstract][Full Text] [Related]
31. Lenalidomide and thalidomide in the treatment of chronic pain. Asher C; Furnish T Expert Opin Drug Saf; 2013 May; 12(3):367-74. PubMed ID: 23442012 [TBL] [Abstract][Full Text] [Related]
32. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guideline. Leitch HA; Buckstein R; Shamy A; Storring JM Crit Rev Oncol Hematol; 2013 Feb; 85(2):162-92. PubMed ID: 22901762 [TBL] [Abstract][Full Text] [Related]
33. Anaemia with inflammation responding to lenalidomide. Haroun F; Mener A; Elkon J; Tabbara I BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27737867 [TBL] [Abstract][Full Text] [Related]
34. Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data. Offidani M; Corvatta L; Caraffa P; Leoni P; Pautasso C; Larocca A; Palumbo A Expert Rev Anticancer Ther; 2014 May; 14(5):499-510. PubMed ID: 24738833 [TBL] [Abstract][Full Text] [Related]
35. An update on the use of lenalidomide for the treatment of multiple myeloma. Zagouri F; Terpos E; Kastritis E; Dimopoulos MA Expert Opin Pharmacother; 2015; 16(12):1865-77. PubMed ID: 26165832 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q). Xiong B; Liu X; Zou P; Fan L; Chen W; Li W; Liu L Leuk Res; 2010 Jul; 34(7):e169-72. PubMed ID: 20122730 [No Abstract] [Full Text] [Related]
37. Pomalidomide in heavily pretreated refractory multiple myeloma: a case report. Palmas A; Piras G; Uras A; Asproni R; Murineddu M; Monne M; Stradoni R; Latte G Future Oncol; 2017 Feb; 13(5s):7-9. PubMed ID: 28116939 [TBL] [Abstract][Full Text] [Related]